Form 8-K · Current report
News Corp 8-K, filed Oct 8, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000218
Summary
News Corp bought back 62,323 shares of its Class A common stock for US$1,783,092.19 on 7 October 2026 under its 2025 repurchase program, at prices between US$28.29 and US$28.85. The company has acquired approximately US$520,061,240 worth of Class A and Class B shares to date under the program, which authorizes up to US$1 billion of repurchases.
Key points
- News Corp's repurchase program authorizes up to US$1 billion in aggregate of its Nasdaq-listed Class A and Class B common stock, authorized as of 15 July 2025.
- The 7 October 2026 buy-back covered 62,323 Class A shares at a total consideration of US$1,783,092.19.
- Prices paid in that buy-back ranged from a low of US$28.29 to a high of US$28.85.
- Goldman Sachs & Co. LLC is named as the broker for the buy-back, and no ASX-listed CDIs will be repurchased under the program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.